These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 23320047)

  • 1. Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?
    Wong H; Yau T
    Therap Adv Gastroenterol; 2013 Jan; 6(1):15-31. PubMed ID: 23320047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
    Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
    Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
    Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I
    World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy in the management of advanced gastric cancer: are we making progress in the era of personalized medicine?
    Wong H; Yau T
    Oncologist; 2012; 17(3):346-58. PubMed ID: 22334453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel targets in the treatment of advanced gastric cancer: a perspective review.
    Fontana E; Smyth EC
    Ther Adv Med Oncol; 2016 Mar; 8(2):113-25. PubMed ID: 26929787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular classifications of gastric cancers: Novel insights and possible future applications.
    Garattini SK; Basile D; Cattaneo M; Fanotto V; Ongaro E; Bonotto M; Negri FV; Berenato R; Ermacora P; Cardellino GG; Giovannoni M; Pella N; Scartozzi M; Antonuzzo L; Silvestris N; Fasola G; Aprile G
    World J Gastrointest Oncol; 2017 May; 9(5):194-208. PubMed ID: 28567184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic profiling of somatic alterations by Oncomine Focus Assay in Korean patients with advanced gastric cancer.
    Park J; Lee SI; Shin S; Hong JH; Yoo HM; Kim JG
    Oncol Lett; 2020 Nov; 20(5):129. PubMed ID: 32934698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
    Ciliberto D; Staropoli N; Caglioti F; Gualtieri S; Fiorillo L; Chiellino S; De Angelis AM; Mendicino F; Botta C; Caraglia M; Tassone P; Tagliaferri P
    Cancer Biol Ther; 2015; 16(8):1148-59. PubMed ID: 26061272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature.
    Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X
    BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Therapies in Advanced Gastric Cancer.
    Patel TH; Cecchini M
    Curr Treat Options Oncol; 2020 Jul; 21(9):70. PubMed ID: 32725377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges.
    Garcia-Pelaez J; Barbosa-Matos R; Gullo I; Carneiro F; Oliveira C
    Mol Oncol; 2021 Nov; 15(11):2841-2867. PubMed ID: 33724653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Therapies in the Management of Advanced-Stage Gastric Cancer.
    Kumar V; Soni P; Garg M; Kamholz S; Chandra AB
    Front Pharmacol; 2018; 9():404. PubMed ID: 30271341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular Subtypes of Gastric Cancer].
    Hatogai K; Doi T
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):281-5. PubMed ID: 27067842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
    Díaz-Serrano A; Angulo B; Dominguez C; Pazo-Cid R; Salud A; Jiménez-Fonseca P; Leon A; Galan MC; Alsina M; Rivera F; Plaza JC; Paz-Ares L; Lopez-Rios F; Gómez-Martín C
    Oncologist; 2018 Sep; 23(9):1092-1102. PubMed ID: 29700210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives.
    Sato Y; Okamoto K; Kawano Y; Kasai A; Kawaguchi T; Sagawa T; Sogabe M; Miyamoto H; Takayama T
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics.
    Birkman EM; Mansuri N; Kurki S; Ålgars A; Lintunen M; Ristamäki R; Sundström J; Carpén O
    Virchows Arch; 2018 Mar; 472(3):369-382. PubMed ID: 29046940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Gastric Cancer-Like Advanced Gastric Cancer versus Advanced Gastric Cancer-Like Early Gastric Cancer.
    Park HS; Lee SY; Hong SN; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    Clin Endosc; 2013 Mar; 46(2):155-60. PubMed ID: 23614125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dawn of precision medicine on gastric cancer.
    Ishii T; Kawazoe A; Shitara K
    Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.